Journals / Turkish Neurosurgery / 2015 / Cilt: 25 - Sayı: 2

Local Application of Corticosteroids Combined with Surgery for the Treatment of Chronic Subdural Hematoma

Hematoma Kronik subdural Hematom Tedavisinde cerrahi ile Kombine olarak Lokal Kortikosteroid Uygulaması

Pages
252–255
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CoNClusIoN: The results suggest that local application of MPSS combined with surgery is a safe and effective method in the management of CSH.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIm: Combination treatment consisting of surgery and pre-or post-operative corticosteroids for chronic subdural hematoma (CSH) tend to have better outcomes than surgery only.
📊
Key Findings & Data:REsulTs: A total of 26 patients were enrolled in this study.
💡
Conclusion & Impact:CoNClusIoN: The results suggest that local application of MPSS combined with surgery is a safe and effective method in the management of CSH.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AIm: Combination treatment consisting of surgery and pre-or post-operative corticosteroids for chronic subdural hematoma (CSH) tend to have better outcomes than surgery only. However, there are many complications after long-term use of corticosteroids. In this study, we evaluated the clinical outcomes of local application of corticosteroids combined with surgery for CSH. mATERIAl and mEThods: We retrospectively analysed the data of the patients undergoing surgery and local application of Methylprednisolone Sodium Succinate for Injection (MPSS) into the hematoma cavity. Neurological status was assessed by Markwalder’s Grading Scale (MGS). Recurrence was defined as deteriorating neurological status with radiological evidence of reaccumulation. REsulTs: A total of 26 patients were enrolled in this study. During the follow-up period, all patients made excellent neurological recovery. 24 (92.3%) patients’ MGS was grade 0 at 12 months after the surgery. There was no mortality or recurrence. 5 patients (19.2%) suffered postoperative complications, of which 2 developed some subdural air collection, 2 had a partial seizure attack and 1 developed an acute epidural hemorrhage. CoNClusIoN: The results suggest that local application of MPSS combined with surgery is a safe and effective method in the management of CSH. It may reduce hematoma recurrence

Özet

AmAÇ: Kronik subdural hematom (KSH) için cerrahi ve preoperatif veya postoperatif kortikosteroidlerden oluşan kombinasyon tedavisinin sonuçları tek başına cerrahiden daha iyi olma eğilimindedir. Ancak kortikosteroidlerin uzun dönem kullanımından sonra birçok komplikasyon vardır. Bu çalışmada KSH için cerrahi ile kombine olarak lokal kortikosteroid uygulamasının klinik sonuçlarını değerlendirdik.yÖNTEm ve GEREÇlER: Hematom boşluğuna Metilprednizolon Sodyum Süksinat (MPSS)ın enjeksiyon ile lokal uygulaması ve cerrahi yapılan hastaların verilerini retrospektif olarak analiz ettik. Nörolojik değerlendirme Markwalder Derecelendirme Ölçeği (MGS) ile yapıldı. Nüks, radyolojik tekrar birikim bulgusuyla birlikte bozulan nörolojik durum olarak tanımlandı. BulGulAR: Çalışmaya toplam 26 hasta dahil edildi. Takip döneminde tüm hastalar nörolojik açıdan mükemmel iyileşme gösterdi. Yirmi dört (%92,3) hastada cerrahiden 12 ay sonra MGS 0 olarakbulundu. Mortalite veya nüks yoktu. Beş hastada (%19,2) postoperatif komplikasyonlar görüldü ve bunların 2'sinde bir miktar subdural hava toplanması, 2'sinde kısmi havale atağı ve 1'inde akut epidural kanama gelişti.soNuÇ: Sonuçlarımız, cerrahiyle kombine olarak yerel MPSS uygulamasının kronik subdural hematom yönetiminde güvenli ve etkin bir yöntem olduğuna işaret etmektedir. Hematom nüksünü de azaltabilir

🔖

Cite This Article

XU, X., LIU, C., LIU, J., PANG, Y., LUO, X., FU, J., ZHOU, L., FAN, Y. (2015). Local Application of Corticosteroids Combined with Surgery for the Treatment of Chronic Subdural Hematoma. Turkish Neurosurgery, Cilt: 25 - Sayı: 2, 252–255. https://ajindex.com/articles/404775

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Aoki N: A new therapeutic method for chronic subdural hematoma in adults: Replacement of the hematoma with oxygen via percutaneous subdural tapping. Surg Neurol 38:253-256,1992 2. Bender MB, Christoff N: Nonsurgical treatment of subdural hematomas. Arch Neurol 31:73-79,1974 3. Berghauser Pont LM, Dirven CM, Dippel DW, Verweij BH, Dammers R: The role of corticosteroids in the management of chronic subdural hematoma: A systematic review. Eur J Neurol 19:1397-1403,2012 4. Decaux O, Cador B, Dufour T, Jego P, Cazalets C, Laurat E, Grosbois B: Nonsurgical treatment of chronic subdural hematoma with steroids: Two case reports. Rev Med Interne 23:788-791,2002 5. Delgado-Lopez PD, Martin-Velasco V, Castilla-Diez JM, Rodriguez-Salazar A, Galacho-Harriero AM, FernandezArconada O: Dexamethasone treatment in chronic subdural haematoma. Neurocirugia (Astur) 20:346-359,2009 6. Dran G, Berthier F, Fontaine D, Rasenrarijao D, Paquis P: Effectiveness of adjuvant corticosteroid therapy for chronic subdural hematoma: A retrospective study of 198 cases. Neurochirurgie 53:477-482,2007 7. Endo S, Hirashima Y, Takaba M, Takaku A: Administration of methylprednisolone acetate into the subdural cavity in an infant with subdural fluid collection. PAF is a good indicator of the efficacy of the treatment. Childs Nerv Syst 14: 354-356,1998 8. Ernestus RI, Beldzinski P, Lanfermann H, Klug N: Chronic subdural hematoma: Surgical treatment and outcome in 104 patients. Surg Neurol 48:220-225,1997 9. Frati A, Salvati M, Mainiero F, Ippoliti F, Rocchi G, Raco A, Caroli E, Cantore G, Delfini R: Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: A prospective study. J Neurosurg 100:24-32,2004 10. Haines DE, Harkey HL, al-Mefty O: The “subdural” space: A new look at an outdated concept. Neurosurgery 32:111-120,1993 11. Hohenstein A, Erber R, Schilling L, Weigel R: Increased mRNA expression of VEGF within the hematoma and imbalance of angiopoietin-1 and -2 mRNA within the neomembranes of chronic subdural hematoma. J Neurotrauma 22:518-528,2005 12. Katano H, Kamiya K, Mase M, Tanikawa M, Yamada K: Tissue plasminogen activator in chronic subdural hematomas as a predictor of recurrence. J Neurosurg 104:79-84,2006 13. Kitakami A, Ogawa A, Hakozaki S, Kidoguchi J, Obonai C, Kubo N: Carbon dioxide gas replacement of chronic subdural hematoma using single burr-hole irrigation. Surg Neurol 43:574-577; discussion 577-578,1995 14. Mack J,